Pride Mobility Products Corp.: FDA filings under this applicant name
FDA lists 20 510(k) clearances under the applicant name “Pride Mobility Products Corp.” (first 2000, latest 2011), across 4 product codes in 1 review panel. Median 510(k) review time under this name: 22 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| INI | Vehicle, Motorized 3-Wheeled | 10 | 10 |
| ITI | Wheelchair, Powered | 6 | 6 |
| INO | Chair, Positioning, Electric | 2 | 2 |
| IOR | Wheelchair, Mechanical | 2 | 2 |
Review panels
- Physical Medicine (20)
Most recent Pride Mobility Products Corp. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K111739 | KIDS ROCK 3 CHAIR | IOR | 2011-08-12 | 52 |
| K091578 | LIFT CHAIR, MODEL T3 | INO | 2009-12-02 | 183 |
| K092961 | JAZZY FRONTIE | ITI | 2009-10-23 | 28 |
| K092088 | VICTORY XL 130 FOUR WHEEL SCOOTER, MODEL SC713 | INI | 2009-07-16 | 7 |
| K091113 | MAXIMA V, THREE WHEEL SCOOTER, MODEL SC900V MAXIMA V, FOUR WHEEL SCOOTER, MODEL SC940V | INI | 2009-05-11 | 24 |
| K090805 | V10, THREE WHEEL SCOOTER, MODEL SC610V, V10, THREE WHEEL SCOOTER, MODEL SC610VPS, V10, FOUR WHEEL SCOOTER, MODEL SC710 | INI | 2009-04-03 | 9 |
| K090524 | GO GO ELITE TRAVELER V THREE WHEEL SCOOTER, MODEL SC40EV | INI | 2009-03-19 | 21 |
| K072165 | VICTORY THREE WHEEL SCOOTER, MODEL: SC610 | INI | 2007-08-17 | 11 |
| K071949 | VICTORY, 4 WHEEL SCOOTER / MODEL, # SC1740 | INI | 2007-08-01 | 19 |
| K070950 | LIFT CHAIR, MODEL C5 | INO | 2007-04-16 | 12 |
10 earlier clearances. See the full list in Caduvo.
Recalls
21 product recalls in 7 recall events; 13 initiated in the last five years. Most recent: 2026-06-25.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Pride Health Care, Inc. (19 510(k)s)
- Pride Health Care Equipment (2 510(k)s)
- Pride Mobility Product Corporration (2 510(k)s)
- Pride Mobility Product Corporation (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Pride Mobility Products Corp.?
FDA lists 20 510(k) clearances under the applicant name “Pride Mobility Products Corp.” (first 2000, latest 2011), across 4 product codes in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Pride Mobility Products Corp.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Pride Mobility Products Corp. is 22 days.
Which FDA product codes appear under Pride Mobility Products Corp.?
The most frequent FDA product codes under this applicant name are INI (Vehicle, Motorized 3-Wheeled, 10); ITI (Wheelchair, Powered, 6); INO (Chair, Positioning, Electric, 2).
Next steps
- See all 20 Pride Mobility Products Corp. clearances with predicates and recalls
- Run predicate analysis for product code INI, Pride Mobility Products Corp.'s most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name (spelling variants such as punctuation and legal suffixes combined); filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.